3,3'-Dibromo-4,4'-dimethoxy-1,1'-biphenyl, 95%, 100mg

Chloro[[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](4'-methoxyacetanilide)palladium(II)]>98.0%(T)200mg

(S)-3-Aminobutanenitrile hydrochloride, 97.0%, 1g

2,3,5,6-Tetrafluoroterephthalaldehyde, 98.0%, 1g

Pyrazolo[1,5-a]pyridine-3-carbonitrile, 96%, 2.5g

2-(N-METHYL-N-ACETYL)-AMINOPYRIDINE, 97.0%, 1g

2-Amino-1-(4-benzyl-piperazin-1-yl)-ethanonedihydrochloride, 98.0%, 1g

E-Plan phase EPLPH 10x/0.25 objective. Working distance 6.61 mm

4-Bromo-N-phenylaniline, 95.0%, 25g

(4-Bromophenoxy)-acetonitrile, 95.0%, 100mg

5-Fluoro-6-methoxynicotinaldehyde, 95.0%, 10g

[2-(Methylamino)pyridin-3-yl]methanol, 97.0%, 100g

1-Ethyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 98%, 100g